EQUILLIUM Trademark

Trademark Overview

On Thursday, May 25, 2017, a trademark application was filed for EQUILLIUM with the United States Patent and Trademark Office. The USPTO has given the EQUILLIUM trademark a serial number of 87464128. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2019. This trademark is owned by Equillium, Inc.. The EQUILLIUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, pharmaceuticals and biologics for the treatment of immune, auto-immune, inflammatory, and lymphoproliferative diseases; Pharmaceutical preparations for use in oncology and immuno-oncology
equillium

General Information

Serial Number87464128
Word MarkEQUILLIUM
Filing DateThursday, May 25, 2017
Status700 - REGISTERED
Status DateTuesday, May 7, 2019
Registration Number5746206
Registration DateTuesday, May 7, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements

Goods and ServicesPharmaceuticals, namely, pharmaceuticals and biologics for the treatment of immune, auto-immune, inflammatory, and lymphoproliferative diseases; Pharmaceutical preparations for use in oncology and immuno-oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 1, 2017
Primary Code005
First Use Anywhere DateWednesday, March 6, 2019
First Use In Commerce DateWednesday, March 6, 2019

Trademark Owner History

Party NameEquillium, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameEquillium, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameEquillium, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Tuesday, May 7, 2019REGISTERED-PRINCIPAL REGISTER
Saturday, March 30, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 29, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 27, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 12, 2019USE AMENDMENT FILED
Wednesday, March 27, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 12, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, September 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 20, 2018EXTENSION 1 GRANTED
Thursday, September 20, 2018EXTENSION 1 FILED
Thursday, September 20, 2018TEAS EXTENSION RECEIVED
Tuesday, May 1, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 19, 2018EXAMINER'S AMENDMENT ENTERED
Friday, January 19, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 19, 2018EXAMINERS AMENDMENT E-MAILED
Friday, January 19, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, January 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 8, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 8, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 28, 2017NON-FINAL ACTION E-MAILED
Monday, August 28, 2017NON-FINAL ACTION WRITTEN
Thursday, August 24, 2017ASSIGNED TO EXAMINER
Thursday, June 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 29, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

equillium oncology pharmaceuticals immune pharmaceutical preparations immuno diseases inflammatory namely biologics